GlassScriptPrepare for your visit
Carla Roberts
Family · Birmingham, AL · NPI 1477950830
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$4,150.28
in general payments reported to CMS, 2019-2025 · $2,879 in 2025
The $2,879 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Inari Medical, INC. $729.54
- Astrazeneca Pharmaceuticals LP $633.36
- Regeneron Healthcare Solutions, INC. $338.74
- Glaxosmithkline, LLC. $259.55
- Genentech USA, INC. $246.06
- Amgen INC. $237.96
Drugs and devices associated with these payments
Flowtriever Catheter, S Ct Thrombectomy System Kit Tezspire Airsupra Dupixent Xolair Fasenra Nucala Neffy Ayvakit Xarelto Ebglyss
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Carla Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11168698/carla-roberts